GeoVax Labs, Inc.
Developing vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
GOVX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1900 LAKE PARK DRIVE, 30080 SMYRNA
- Website:
- https://www.geovax.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
GeoVax Labs, Inc. is a clinical-stage biotechnology company that develops human vaccines and immunotherapies for infectious diseases and cancer, utilizing novel proprietary platforms. Its lead oncology program is Gedeptin®, a therapy for advanced head and neck cancers which has completed enrollment in a Phase 1/2 clinical trial. The company's lead infectious disease program is GEO-CM04S1, a next-generation COVID-19 vaccine in Phase 2 trials for high-risk populations and as a booster. GeoVax's development pipeline also includes programs for Mpox, hemorrhagic fever viruses (Ebola, Marburg), malaria, Zika virus, and various solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all GeoVax Labs, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GeoVax Labs, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GeoVax Labs, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
